AGP Picks
View all

Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

Press releases published on November 5, 2026

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in November
Forward Therapeutics Announces U.S. FDA IND Clearance to Initiate Phase 2 Study of FT2109 in Psoriatic Arthritis
LaunchDarkly Introduces Release Autopilot, Automating Release Safeguards for AI-Written Code
Grace Therapeutics Announces Participation in Upcoming Industry and Investor Events in November 2026
Incyclix Bio Establishes Steering Committee of Leading Breast Cancer Experts to Guide INX-315 Clinical Development
AceUp Elevates Leadership Development Amid AI Transformation for NTT DATA Business Solutions with Ally 3.0
Arcutis Begins Enrolling Phase 3 Study Evaluating ZORYVE® (roflumilast) Cream 0.3% in Moderate to Severe Atopic Dermatitis
RemoFirst Launches a Global Infrastructure to Help Companies Manage and Pay Experts for AI Training
Nova Anchora Announces $23 Million Financing to Advance Topical Collagen VII Therapy for Dystrophic Epidermolysis Bullosa
Forge Nano Completes Acquisition of HZO, Uniting Two Nanoscale Coating Platforms for Electronics, Semiconductor and Defense Markets
Ovid Therapeutics to Participate in Upcoming Investor Conferences
PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product
Immutep Announces Upcoming Poster Presentations at CTOS 2026 and ESMO Immuno-Oncology & Advanced Therapies Congress 2026
Science 37 Named 2026 “BioTechnology Innovation of the Year” for its Direct-to-Patient Clinical Trial Delivery Model
Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights
electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Filana Therapeutics Reports Q3 2026 Financial Results and Provides Business Update
BriaCell Awarded 2026 “Immunotherapy Solution of the Year” By BioTech Breakthrough
Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Journal of Colorado

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.